MX2022013283A - Composiciones para limpieza de colon y tratamiento de trastornos gastrointestinales. - Google Patents

Composiciones para limpieza de colon y tratamiento de trastornos gastrointestinales.

Info

Publication number
MX2022013283A
MX2022013283A MX2022013283A MX2022013283A MX2022013283A MX 2022013283 A MX2022013283 A MX 2022013283A MX 2022013283 A MX2022013283 A MX 2022013283A MX 2022013283 A MX2022013283 A MX 2022013283A MX 2022013283 A MX2022013283 A MX 2022013283A
Authority
MX
Mexico
Prior art keywords
compositions
gastrointestinal disorders
treatment
colon cleansing
present
Prior art date
Application number
MX2022013283A
Other languages
English (en)
Inventor
Robert Solinga
Mark G Currie
Christopher Leitheiser
Original Assignee
Ironwood Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ironwood Pharmaceuticals Inc filed Critical Ironwood Pharmaceuticals Inc
Publication of MX2022013283A publication Critical patent/MX2022013283A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

La presente invención proporciona péptidos y composiciones que son útiles para el tratamiento de trastornos gastrointestinales o para limpieza de colon. La presente invención también proporciona composiciones y métodos para tratamiento de trastornos gastrointestinales y composiciones farmacéuticas para realizar los mismos. En algunas modalidades, estas composiciones farmacéuticas incluyen formas de dosis oral.
MX2022013283A 2015-05-01 2017-10-30 Composiciones para limpieza de colon y tratamiento de trastornos gastrointestinales. MX2022013283A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201562156077P 2015-05-01 2015-05-01

Publications (1)

Publication Number Publication Date
MX2022013283A true MX2022013283A (es) 2022-12-13

Family

ID=55953439

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2017013928A MX2017013928A (es) 2015-05-01 2016-04-29 Composiciones para limpieza de colon y tratamiento de trastornos gastrointestinales.
MX2022013283A MX2022013283A (es) 2015-05-01 2017-10-30 Composiciones para limpieza de colon y tratamiento de trastornos gastrointestinales.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2017013928A MX2017013928A (es) 2015-05-01 2016-04-29 Composiciones para limpieza de colon y tratamiento de trastornos gastrointestinales.

Country Status (23)

Country Link
US (2) US10618938B2 (es)
EP (2) EP4218789A3 (es)
JP (4) JP6930919B2 (es)
KR (1) KR20180005675A (es)
CN (2) CN114716514A (es)
BR (1) BR112017023539A2 (es)
CA (2) CA3172777A1 (es)
CY (1) CY1126031T1 (es)
DK (1) DK3288578T3 (es)
EA (1) EA201792401A1 (es)
ES (1) ES2947591T3 (es)
FI (1) FI3288578T3 (es)
HR (1) HRP20230381T1 (es)
HU (1) HUE061954T2 (es)
LT (1) LT3288578T (es)
MA (1) MA41985B1 (es)
MD (1) MD3288578T2 (es)
MX (2) MX2017013928A (es)
PL (1) PL3288578T3 (es)
PT (1) PT3288578T (es)
RS (1) RS64160B1 (es)
SI (1) SI3288578T1 (es)
WO (1) WO2016178979A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2017273857B2 (en) 2016-06-01 2021-08-19 Athira Pharma, Inc. Compounds
AU2022396412A1 (en) * 2021-11-24 2024-05-30 Ironwood Pharmaceuticals, Inc. Synthetic process for production of modified gcc receptor agonists
CA3238636A1 (en) * 2021-11-24 2023-06-01 Christopher Leitheiser Synthetic process for production of modified gcc receptor agonists
CA3238619A1 (en) * 2021-11-29 2023-06-01 Michael Gerber Pharmaceutical compositions for the treatment of visceral pain

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH689139A5 (de) 1995-04-03 1998-10-30 Cerbios Pharma Sa Verfahren zur Herstellung einer liposomalen, in Wasser dispergierbaren, oral zu verabreichenden, festen, trockenen therapeutischen Formulierung.
US5912014A (en) 1996-03-15 1999-06-15 Unigene Laboratories, Inc. Oral salmon calcitonin pharmaceutical products
SG168407A1 (en) * 2003-01-28 2011-02-28 Ironwood Pharmaceuticals Inc Methods and compositions for the treatment of gastrointestinal disorders
US7494979B2 (en) * 2003-06-13 2009-02-24 Ironwood Pharmaceuticals, Inc. Method for treating congestive heart failure and other disorders
CA2619650A1 (en) * 2005-08-19 2007-02-22 Microbia, Inc. Methods and compositions for the treatment of gastrointestinal disorders
EP2331561A4 (en) * 2008-09-03 2013-02-27 Xenome Ltd PEPTIDE CONJUGATE LIBRARIES AND METHODS OF MAKING SAME
UA108636C2 (xx) * 2010-02-17 2015-05-25 Пептид
EP2958577A2 (en) * 2013-02-25 2015-12-30 Synergy Pharmaceuticals Inc. Guanylate cyclase receptor agonists for use in colonic cleansing
WO2016015055A1 (en) * 2014-07-25 2016-01-28 Ironwood Pharmaceuticals, Inc. Colon cleansing compositions

Also Published As

Publication number Publication date
LT3288578T (lt) 2023-04-25
HUE061954T2 (hu) 2023-09-28
CY1126031T1 (el) 2023-11-15
MD3288578T2 (ro) 2023-08-31
CN108040482B (zh) 2022-03-29
WO2016178979A1 (en) 2016-11-10
EA201792401A1 (ru) 2018-05-31
EP4218789A2 (en) 2023-08-02
JP6930919B2 (ja) 2021-09-01
MA41985A (fr) 2018-03-07
MX2017013928A (es) 2018-01-15
JP2018519254A (ja) 2018-07-19
CA2984437A1 (en) 2016-11-10
US20240199697A1 (en) 2024-06-20
CN108040482A (zh) 2018-05-15
JP2020203954A (ja) 2020-12-24
JP2022121734A (ja) 2022-08-19
PT3288578T (pt) 2023-03-28
US20180148476A1 (en) 2018-05-31
EP3288578B1 (en) 2023-03-15
KR20180005675A (ko) 2018-01-16
FI3288578T3 (fi) 2023-05-03
HRP20230381T1 (hr) 2023-07-07
EP4218789A3 (en) 2023-09-27
RS64160B1 (sr) 2023-05-31
CN114716514A (zh) 2022-07-08
JP2024015335A (ja) 2024-02-01
CA3172777A1 (en) 2016-11-10
ES2947591T3 (es) 2023-08-11
BR112017023539A2 (pt) 2018-08-14
PL3288578T3 (pl) 2023-08-14
US10618938B2 (en) 2020-04-14
MA41985B1 (fr) 2023-04-28
SI3288578T1 (sl) 2023-07-31
EP3288578B8 (en) 2023-03-29
DK3288578T3 (da) 2023-05-01
EP3288578A1 (en) 2018-03-07

Similar Documents

Publication Publication Date Title
EA201890325A1 (ru) Пептидные ингибиторы рецептора интерлейкина-23 и их применение для лечения воспалительных заболеваний
EA201290322A1 (ru) Лечение желудочно-кишечных расстройств
GB2541571A (en) Pharmaceutical compositions
GEP20247593B (en) Compositions and methods of inhibiting masp-3 for the treatment of various diseases and disorders
MX2019000588A (es) Moduladores de la somatostatina y usos de los mismos.
MX2020001774A (es) Composiciones y métodos para tratar enfermedad colestásica.
MX2016012574A (es) Compuestos heteroarilo sustituidos y metodos de uso.
MX2019010949A (es) Moduladores de somatostatina y usos de los mismos.
MX2017016134A (es) Aril dihidro-2h-benzo[b][1,4]oxazina sulfonamida y compuestos relacionados para uso como agonistas de rory y el tratamiento de enfermedad.
MY195081A (en) Pladienolide Pyridine Compounds and Methods of use
EA201792157A1 (ru) Имидазопиразиноны в качестве ингибиторов pde1
MX2022013283A (es) Composiciones para limpieza de colon y tratamiento de trastornos gastrointestinales.
MX2017014456A (es) Usos terapeuticos de l-4-cloroquinurenina.
SG10201805646WA (en) Angiopoietin-like 4 antibodies and methods of use
EA201791937A1 (ru) Противовоспалительные полипептиды
EA201790893A1 (ru) Способы лечения офтальмологических расстройств
EA201691896A1 (ru) Соединения и способы их применения
MX2020001256A (es) Compuestos para la prevencion y el tratamiento de trastornos medicos y usos de los mismos.
SG10201805890QA (en) Compositions and methods for treatment of abnormal cell growth
MX2017006692A (es) Trastornos neurodegenerativos.
ZA201903222B (en) Compositions and methods for the treatment of gastrointestinal polyps
CY1119674T1 (el) Θεραπεια και προληψη της νοσου αλτσχαϊμερ (ad)
IL284117A (en) Preparations, devices and methods for the treatment of disorders based on overdose and compensation
MX2017003949A (es) Derivados peptidicos novedosos y sus usos.
MY182818A (en) Compositions for the treatment of fibrosis and fibrosis-related conditions